Introduction

An outbreak of unknown causes of pneumonia cases was first identified in Wuhan, China in December 2019, with clinical presentations similar to viral pneumonia [1]. Genomic analysis on the RNA samples extracted from the bronchoalveolar-lavage fluid of the pneumonia patients by Illumina sequencing and nanopore sequencing identified the viral contigs matched to the genome of lineage B of the genus betacoronavirus and with 85% identity to the genome of a bat severe acute respiratory syndrome (SARS)-like coronavirus (bat-SL-CoVZC45, MG772933.1) [2], indicating that this coronavirus disease (COVID-19) is caused by a novel SARS coronavirus (SARS-CoV)-resembled virus (SARS-CoV-2). Target cell infection by SARS-CoV is mediated by the spike protein of coronavirus and the host cellular receptor, angiotensin-converting enzyme 2 (ACE2) [3]. Similarly, a recent study suggests that the cellular entry by SARS-CoV-2 also depends on ACE2 as well as type II transmembrane serine protease (TMPRSS2) [4]. This implies that the identification of ACE2 and TMPRSS2 expression in human tissues can predict the potential infected cells and their respective influences in COVID-19 patients.

Our center previously reported that no SARS-CoV can be found in tear swab and conjunctival scra** by reverse transcription-polymerase chain reaction (RT-PCR) or isolated by viral culture [5], and the SARS patients also did not show any observable ocular manifestations [6]. In contrast, conjunctivitis was suggested as a pre-symptomatic sign before the onset of COVID-19, possibly by the exposure of infectious droplets without proper protection of goggles [7]. Critically, SARS-CoV-2 can be detected in tears and conjunctival secretions from a COVID-19 patient with conjunctivitis by RT-PCR [Statistical analysis

Each experiment was repeated three times. The expression data were presented as mean ± standard deviation. Mean of the three repeated experiments was compared by one-way analysis of variance with post-hoc Tukey’s test for multiple testing correction. All statistical analyses were performed by the commercially available software (IBM SPSS Statistics 22; SPSS Inc., Chicago, IL). Significance was defined as p < 0.05.

Results

Expression of ACE2 and TMPRSS2 genes in human conjunctival and pterygium cells

RT-PCR analysis showed that both ACE2 primers consistently amplified the ACE2 gene in 2 out of 3 conjunctival and pterygium cell lines (Fig. 1a). Consistent expression of ACE2 gene could be found in TM, HUVEC, HaCaT, PDLSC, A549, and HepG2 cells. HaCaT cells showed strongest expression of ACE2 among the tested cell lines, followed by HUVEC and HepG2 cells. Conjunctival cells moderately expressed ACE2, where pterygium cells showed weak expression. On the contrary, consistent expression of TMPRSS2 gene could only be found in 1 out of 3 pterygium cell lines, and no consistent expression of TMPRSS2 gene was observed in any conjunctival cells (Fig. 1b). In addition, consistent TMPRSS2 expression could be found in HUVEC, HaCaT, and A549 cells. Among the tested cell lines, HUVEC showed strongest expression of TMPRSS2 gene.

Fig. 1: RT-PCR analysis of ACE2 and TMPRSS2 gene expression in human primary conjunctival, pterygium, mesenchymal stem cells, and other cell lines.
figure 1

Full-length primary pterygium and conjunctiva tissues (each n = 3) were collected, dissociated and maintained in cell culture. Human ocular cell lines, including retinal pigment epithelial cells ARPE-19, lens epithelial cells B3, primary trabecular meshwork (TM) cells and retinoblastoma cells Y79, human primary mesenchymal stem cells (MSCs), including bone marrow-derived MSCs (BM-MSCs), adipose-derived stem cells (ASC), and periodontal ligament-derived stem cells (PDLSC), as well as other human tissue cell lines, including human umbilical vein endothelial cells (HUVEC), lung epithelial carcinoma cells A549, liver hepatocellular carcinoma cells HepG2 and keratinocytes HaCaT, were also culture and collected. Total RNA was extracted and reverse transcribed (RT). The expression of (a) ACE2 and (b) TMPRSS2 genes was determined by polymerase chain reaction (PCR) with 2 primers for each gene. Housekee** β-actin gene ACTB was used for normalization.

Full size image

SYBR green PCR analysis confirmed that HaCaT cells had higher expression of ACE2 gene with the ΔCt of 9.01 ± 0.10 and 7.44 ± 0.04 for primers 1 and 2, respectively as compared with other cell lines (Fig. 2a). Compared with the lung epithelial carcinoma cells A549, HaCaT cells (primer 1: 801.6-fold, p < 0.001; primer 2: 187.2-fold, p < 0.001) and ASCs (primer 1: 6.4-fold, p < 0.001; primer 2: 7.5-fold; p = 0.034) consistently showed significant higher expression for the 2 ACE2 primers, whereas human TM cells consistently showed significant lower expression (primer 1: 3.8-fold, p = 0.027; primer 2: 6.2-fold, p = 0.048). In contrast, 2 conjunctival cell lines, ARPE-19, HUVEC, and HepG2 cells only showed differential expression in the ACE2 gene amplification by primer 1 as compared with the A549 cells (p < 0.05). There was no consistent significant differential expression of TMPRSS2 gene as compared with the A549 cells (Fig. 2b). Pterygium sample 3 and ASCs showed significant higher TMPRSS2 expression in primer 1, whereas BM-MSCs, B3, and Y79 cells showed significant lower expression in primer 2. The conjunctival cells showed similar expression of TMPRSS2 gene as compared with the A549 cells.

Fig. 2: SYBR green analysis of ACE2 and TMPRSS2 gene expression in human primary conjunctival, pterygium, mesenchymal stem cells, and other tissue cell lines.
figure 2

Full-length primary pterygium and conjunctiva tissues (each n = 3) were collected, dissociated and maintained in cell culture. Human ocular cell lines, including retinal pigment epithelial cells ARPE-19, lens epithelial cells B3, primary trabecular meshwork (TM) cells and retinoblastoma cells Y79, human primary mesenchymal stem cells (MSCs), including bone marrow-derived MSCs (BM-MSCs), adipose-derived stem cells (ASC), and periodontal ligament-derived stem cells (PDLSC), as well as other human tissue cell lines, including human umbilical vein endothelial cells (HUVEC), lung epithelial carcinoma cells A549, liver hepatocellular carcinoma cells HepG2 and keratinocytes HaCaT, were also culture and collected. Total RNA was extracted and reverse transcribed. The expression of (a) ACE2 and (b) TMPRSS2 genes was determined by SYBR green polymerase chain reaction (PCR) with 2 primers for each gene. Housekee** β-actin gene ACTB was used for normalization. Relative expression levels (ΔCt) of different mouse tissues were compared with that of A549 cells. *p < 0.05; **p < 0.01; ***p < 0.001.

Full size image

Expression of Ace2 and Tmprss2 genes in mouse ocular tissues

All collected mouse tissues could express the Ace2 gene by the 2 primers in the RT-PCR analysis (Fig. 3a). Stronger expression of Ace2 gene could be found in cornea and liver among the tested tissues, whereas lung, heart, kidney, and brain showed moderate expression. In contrast, expression of Tmprss2 gene could only consistently be found in mouse cornea, lung, liver, kidney, and brain tissues (Fig. 3b). Cornea and liver had stronger expression of Tmprss2 gene among the collected tissues, whereas lung and kidney showed moderate expression.

Fig. 3: RT-PCR analysis of Ace2 and Tmprss2 gene expression in mouse ocular and systemic tissues.
figure 3

Eight-month-old C57BL/6 mice (n = 3) were sacrificed, and different ocular tissues, including cornea, iris, lens, retina and optic nerve, as well as other tissues, including lung, heart, kidney, liver, spleen, and brain, were collected. Total RNA was extract and reverse transcribed (RT). The expression of (a) Ace2 and (b) Tmprss2 genes was determined by polymerase chain reaction (PCR) with 2 primers for each gene. Housekee** β-actin gene Actb was used for normalization.

Full size image

SYBR green PCR analysis confirmed the expression of Ace2 gene in all collected mouse tissues (Fig. 4a), with stronger expression in lung (primer 1 ΔCt: 7.76 ± 0.95 and primer 2 ΔCt: 8.33 ± 0.18) and kidney (primer 1 ΔCt: 5.26 ± 0.24 and primer 2 ΔCt: 4.79 ± 0.25). Compared with the lung tissue, only kidney tissue consistently showed significant higher expression for the 2 Ace2 primers by 5.7 and 11.6-fold, respectively (p < 0.01). Other tissues, except heart, showed significantly lower Ace2 gene expression than the lung (p < 0.01). Cornea tissue had 8.7 (p < 0.001) and 4.3-fold (p = 0.001) lower expression for the Ace2 primer 1 and primer 2 respectively as compared with the lung tissue. For the Tmprss2 gene, the expression could be found in all collected mouse tissues (Fig. 4b). Strongest expression was observed in kidney tissue with the ΔCt of 3.55 ± 0.11 and 3.37 ± 0.10 for primer 1 and 2, respectively, followed by the lung, cornea, and liver. Coherent to the Ace2 gene, only kidney tissue consistently showed significant higher expression for the 2 Tmprss2 primers by 9.6 and 9.7-fold, respectively (p < 0.01) as compared with the lung tissue. In contrast, iris, lens, retina, optic nerve, heart, spleen, and brain showed significant lower Tmprss2 gene expression than the lung tissue. The expressions of Tmprss2 gene in cornea and liver were comparable to those in the lung tissue.

Fig. 4: SYBR green PCR analysis of Ace2 and Tmprss2 gene expression in mouse ocular and systemic tissues.
figure 4

Eight-month-old C57BL/6 mice (n = 3) were scarified, and different ocular tissues, including cornea, iris, lens, retina, and optic nerve, as well as other tissues, including lung, heart, kidney, liver, spleen, and brain, were collected. Total RNA was extracted and reverse transcribed. The expression of (a) Ace2 and (b) Tmprss2 genes was determined by SYBR green polymerase chain reaction (PCR) with 2 primers for each gene. Housekee** β-actin gene Actb was used for normalization. Relative expression levels (ΔCt) of different mouse tissues were compared with that of mouse lung tissue. *p < 0.05; **p < 0.01; ***p < 0.001.

Full size image

Discussion

Results from this study showed that: (1) consistent expression of ACE2 and TMPRSS2 genes could only be observed in the conjunctival cells and pterygium cells from some pterygium patients; (2) mouse cornea had comparable expression of Tmprss2 gene and lower but prominent Ace2 gene expression than the lung tissue; (3) high expression of Ace2 and Tmprss2 genes could be found in mouse cornea. Collectively, our results indicate that, with reference to the Ace2 and Tmprss2 expression in the lung, cornea rather than conjunctiva could potentially be infected by SARS-CoV-2.

COVID-19 pandemic is a global issue. More than 200 countries/territories have been affected, with more than 1 million confirmed cases. SARS-CoV-2 has been discovered as the pathogenic cause of COVID-19 [2]. It is believed that person-to-person transmission of COVID-19 is mainly due to the infection by SARS-CoV-2 through respiratory droplets and close contact [20]. The infection and cellular entry of SARS-CoV-2 are mediated by the spike glycoprotein of coronavirus and the host cellular SARS-CoV receptor ACE2 [4, 21]. In addition to ACE2, TMPRSS2 is required to promote SARS-CoV entry by ACE2 cleavage to promote viral uptake and SARS-CoV spike protein cleavage to activates the spike protein for membrane fusion [22]. Therefore, understanding the coexpression of ACE2 and TMPRSS2 can predict the possibility of SARS-CoV-2 infection in human system.

In this study, we, for the first time, demonstrated ACE2 gene expression in some but not all primary human conjunctival and pterygium cells (Fig. 1a). Similarly, consistent expression of TMPRSS2 gene could only be found in 1 out of 3 investigated pterygium samples, but not in any conjunctival cells (Fig. 1b). Considering the necessity of both ACE2 and TMPRSS2 for SARS-CoV-2 infection, our results suggest that conjunctiva would be less likely to be infected by SARS-CoV-2, whereas pterygium possesses some possibility of SARS-CoV-2 infection. On the contrary, consistent expression of ACE2 and TMPRSS2 genes can be found in endothelial cells HUVEC, epidermal keratinocytes HaCaT, and lung epithelial carcinoma cells A549, indicating that lung, skin, and blood capillaries are the potential sites with SARS-CoV-2 infection. To expand our understanding of the possible tissues influenced by SARS-CoV-2 infection, we determined the expression of Ace2 and Tmprss2 genes in mouse tissues (Fig. 3). We report the expression of Ace2 and Tmprss2 genes in mouse cornea tissue, but not in iris, lens, retina, and optic nerve. Our results indicated that cornea could be a susceptible site for SARS-CoV-2 infection as their expressions in cornea are comparable to that in lung tissue (Fig. 4). Apart from cornea, we found expression of Ace2 and Tmprss2 genes in lung, liver, kidney, and brain. A recent RNA sequencing analysis on 13 human tissues reports the expression of ACE2 mainly in lung AT2, liver cholangiocyte, colon colonocytes, oesophagus keratinocytes, ileum enterocytes, rectum enterocytes, stomach epithelial cells, and kidney proximal tubules, and ACE2 expression was also observed in pericytes and fibroblasts from the eye tissue [23]. ACE2 expression can also be noted in the epithelial cells of oral mucosa, vascular endothelial cells, type II pneumocytes, kidney, heart, and the central nervous system [24,25,26,27,28]. On the other hand, TMPRSS2 expression has been reported in primary human airway cells, type II pneumocytes and cancers [29, 30].

ACE2 is a negative regulator of the renin-angiotensin-aldosterone system, controlling the blood pressure, body fluid homeostasis as well as the inflammatory and fibrotic effects [31]. In the eye, ACE2 expression was found in ciliary body, retina, and photoreceptors [32, 33]. Activation of endogenous Ace2 by diminazene aceturate facilitates the drainage of aqueous humor and decreases intraocular pressure in a rat model of glaucoma [34]. Overexpression of ACE2 can also ameliorate the inflammatory response in experimental autoimmune uveitis model and amyloid β-treated human RPE [35, 36]. Although ACE2 is critical for SARS-CoV infection, SARS-CoV infection and spike protein of SARS-CoV would reduce ACE2 expression, and injection of SARS-CoV spike protein worsens acute lung failure in mice with the enhanced renin-angiotensin pathway [37]. Considering the correlation of reduced ACE2 expression after SARS-CoV infection and the anti-inflammatory role of ACE2, it could explain the possible occurrence of conjunctivitis in patients with SARS-CoV-2 infection [7, 8].

TMPRSS2, belonging to the TMPRSS2 family, cleaves the coronavirus spike protein for coronavirus infections, which lack of Tmprss2 reduces the severity of lung pathology after infection by SARS-CoV and Middle East Respiratory Syndrome-CoV [38]. In addition to the coronavirus spike protein, TMPRSS2 is also the major protease for the cleavage of the influenza virus surface glycoprotein hemagglutinin, which is prerequisite for membrane fusion and virus infectivity [29]. Apart from TMPRSS2, membrane alanyl aminopeptidase (ANPEP), dipeptidyl peptidase 4, and glutamyl aminopeptidase have been suggested as the candidate coreceptors for ACE2 [23]. The roles and mechanisms of these coreceptor peptidases in SARS-CoV-2 infection as well as the possible therapeutic treatments for COVID-19 warrant further investigations.

In summary, this study revealed the expression of SARS-CoV-2 receptor ACE2 and serine protease TMPRSS2 genes in human conjunctival and pterygium cells as well as mouse cornea tissue. Considering the high expression of Ace2 and Tmprss2 in cornea, precaution practices are necessary to prevent possible SARS-CoV-2 infection through ocular surface.

Summary

What was known before

  • ACE2 is a negative regulator of the renin-angiotensin-aldosterone system, controlling the blood pressure, body fluid homeostasis, inflammation, and fibrosis.

  • In the eye, ACE2 expression was found in ciliary body, retina, and photoreceptors.

What this study adds

  • Consistent expression of ACE2 and TMPRSS2 genes was only observed in the conjunctival cells and pterygium cells from some pterygium patients.

  • Mouse cornea had comparable expression of Tmprss2 gene and lower but prominent Ace2 gene expression than the lung tissue.